Medtronic Warns About Faulty Defibrillator Batteries

Law360, New York (September 11, 2009, 2:47 PM EDT) -- Medtronic Inc. has notified doctors that thousands of implanted defibrillators may contain faulty batteries, but the medical technology giant maintains the problem poses no great danger to patients.

The advisory went out earlier this week, alerting doctors to potential battery defects in a subset of 6,300 implanted defibrillators that could cause the batteries to lose power ahead of schedule, hastening the need for a replacement.

The suspect batteries are used in Medtronic’s pacemaker devices, particularly the Concerto cardiac resynchronization therapy defibrillator, which synchronizes the pumping of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.